Isabel Takano Oba
Instituto Adolfo Lutz
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Isabel Takano Oba.
Revista Do Instituto De Medicina Tropical De Sao Paulo | 1998
João Renato Rebello Pinho; Laura Massami Sumita; Regina Célia Moreira; Vanda Akico Ueda Fick de Souza; Cláudia Patara Saraceni; Isabel Takano Oba; Mariana Carvalho e Silva de Carvalho; Cláudio Sérgio Pannuti
To evaluate the prevalence of antibodies against hepatitis A in two socioeconomically distinct populations, 101 and 82 serum samples from high and low socioeconomic groups, respectively, were analysed for the presence of IgG anti-HAV using a commercial ELISA. The prevalence in low socioeconomic level subjects was 95.0%, whereas in high socioeconomic subjects was only 19.6% (p < 0.001). These data show a duality in Brazil: anti-HAV prevalence in low socioeconomic subjects is similar to that of developing countries, while in high socioeconomic subjects, a pattern typical of developed countries is found. The control of this infection in our country is primarily related to the improvement of sanitation, but especially for high socioeconomic level populations, the use of vaccination against hepatitis A is strongly advisable to avoid the occasional appearance of this disease in adults.
Revista Do Instituto De Medicina Tropical De Sao Paulo | 2000
Isabel Takano Oba; Angela Maria Miranda Spina; Cláudia Patara Saraceni; Marcílio Figueiredo Lemos; Rita de Cássia Ferreira Andrade Senhoras; Regina Célia Moreira; Celso Francisco Hernandes Granato
The possibility of detecting acute infection and immunity using body fluids that are easier to collect than blood, mainly in children, would facilitate the investigation and follow-up of outbreaks of hepatitis A (HAV). Our study was carried out to evaluate the detection of anti-HAV IgM, IgA and total antibodies in saliva using serum samples as reference. Forty three paired serum and saliva samples were analyzed. From this total, 24 samples were obtained from children and 1 from one adult during the course of acute hepatitis A; an additional 18 samples were obtained from health professionals from Adolfo Lutz Institute. The sensitivity to detect anti-HAV IgM was 100% (95%CI: 79.1 to 100.0%), employing saliva as clinical samples. In detecting anti-HAV IgA, the sensitivity was 80. 8% (95%CI: 60.0 to 92.7%) and for the total antibodies was 82.1% (95%CI: 62.4 to 93.2%). The specificity was 100% for each. The rate of agreement was high comparing the results of serum and saliva samples for detecting HAV antibodies. We conclude that saliva is an acceptable alternative specimen for diagnosing acute hepatitis A infection, and for screening individuals to receive hepatitis A vaccine or immunoglobulin.
Memorias Do Instituto Oswaldo Cruz | 2010
Regina Célia Moreira; Marta Mitiko Deguti; Marcílio Figueiredo Lemos; Cláudia Patara Saraceni; Isabel Takano Oba; Angela Maria Miranda Spina; Alessandra Stilhano Nascimento-Lima; Jorge Fares; Raymundo Soares Azevedo; Michele Soares Gomes-Gouvêa; Flair José Carrilho; João Renato Rebello Pinho
The aim of this study was to determine the prevalence and the incidence of hepatitis B virus (HBV) among haemodialysis (HD) subjects and to evaluate whether testing for serological markers at the time of admission is suitable for HBV screening in this population. One hundred twenty-three patients belonging to two HD centres from São Paulo, Brazil, were tested prospectively. HBV DNA was detected by polymerase chain reaction (PCR) in each of the prospective subjects (n = 123) during one year. Additionally, all samples (n = 1,476) were analysed for HBV serological markers. The prevalence of hepatitis B core antibody (anti-HBc), hepatitis B surface antigen (HBsAg) and HBV DNA were 34.1%, 15.4% and 8.1%, respectively, while the incidence was null. Fluctuation in HBV serology was observed in one patient. Only 37.8% (17/45) of cases responded to the HBV vaccine. Our results suggest that employing more than one HBV marker and repeated follow-up evaluations may improve HBV screening in HD units.
Jornal Brasileiro De Patologia E Medicina Laboratorial | 2007
Regina Célia Moreira; Cláudia Patara Saraceni; Isabel Takano Oba; Angela Maria Miranda Spina; João Renato Rebello Pinho; Luiza Terezinha Madia de Souza; Tereza Mitiko Omoto; Cecília Kitamura; Gabriel Wolf Oselka
OBJECTIVES: To determine the prevalence of HBsAg and anti-HBs and to evaluate the response of intradermal hepatitis vaccination in healthcare workers non-responsive to previous repeated intramuscular vaccination. MATERIAL AND METHOD: All of the employees from Instituto Adolfo Lutz were invited to participate on this study. Serum samples were obtained and HBsAg and anti-HBs were detected using commercial kits (Abbott® Laboratories). Employees were submitted to the conventional three-dose vaccination by intramuscular route. To those employees who did not respond to intramuscular vaccination, 5 µg doses of Engerix® B were then administered by intradermal route up to nine doses. RESULTS: Four hundred and four healthcare workers were enrolled in this study. Initially, two (0.5%) and 42 (10.4%) were HBsAg and anti-HBs reagent, respectively. Among the 360 negative volunteers, 316 (87.8%) received three vaccine doses and in 259 of them, serum samples were collected to evaluate vaccine efficacy. Among them, 242 (93.4%) showed antibodies titer higher than 10 UI/l. Intradermal vaccination was carried out in five volunteers and all of them responded to this vaccine administration route. CONCLUSION: The prevalence of hepatitis B was not higher than in general population. Intradermal vaccine administration could be a good alternative in people that did not respond to previous intramuscular route.
Revista Do Instituto De Medicina Tropical De Sao Paulo | 1992
Ester Cerqueira Sabino; Elvira Maria Guerra; Isabel Takano Oba; Angela Maria Miranda Spina; Adelaide José Vaz
Hepatitis B is a severe disease when acquired during the neonatal period. The identification of the infected pregnant women allows prevention of newborn infection by active and passive immunization soon after birth. We studied pregnant women in their first visit to eight different primary medical centers in Butantan, a subdistrict of S. Paulo city. 477 samples were tested for anti-HBc. From 44 (9.2%) anti-HBc positive samples, 2 (0.4%) were HBsAg positive and 37 (7.7%) were anti-HBs positive. A risk factor for hepatitis B could only be detected in 8 (18.9%) of the 44 anti-HBc positive samples
Revista Do Instituto De Medicina Tropical De Sao Paulo | 1989
Flair José Carrilho; Maria Lúcia Queiróz; Luiz Caetano da Silva; Luís Edmundo Pinto da Fonseca; C. F. H. Granato; Isabel Takano Oba; Leda Obara
Schedule for vaccination against HBV infection has usually been based on three separate injections of 20 mcg of the vaccine by intramuscular route. One of the main shortcomings to its use in large scale programs has been its high cost. Ninety out of 300 health workers were submitted to three injections of 2 mcg of plasma-derived vaccine (PDV) by intradermal (ID) route on days 0, 30, and 180. Anti-HBs was detected in 74 (82.2%) after the second dose and in 80 (88.9%) after the third dose, a non-significant difference. However, levels above 10 times the cut-off were observed in 29 (32.2%) and 77 (85.5%), respectively (p less than 0.001). The results showed that a low-dose schedule is effective when used in health workers and should be tried with other risk groups.
Revista Brasileira De Epidemiologia | 2014
Maria Célia Cunha Ciaccia; Regina Célia Moreira; Marcílio Figueiredo Lemos; Isabel Takano Oba; Gilda Porta
OBJECTIVE To estimate the prevalence of the serological markers anti-HBc, HBsAg and anti-HBs of hepatitis B and anti-HCV of hepatitis C among children and teenagers enrolled at daycare facilities, kindergartens and municipal elementary education network in the city of Santos, São Paulo, Brazil. METHODS A cross-sectional study was carried out from June 28 to December 14, 2007, in which 4,680 finger-prick blood samples were collected from children and teenagers. A survey questionnaire was applied to their family members. The sample was dimensioned using the software Epi Info version 6 with expected frequency of 1%, acceptable error of 0.5% and confidence interval of 95%. The serological tests were performed using the ELISA technique. The molecular analysis was performed using the technique of polymerase chain reaction in House. RESULTS Age of the studied population ranged from 7 months to 18 years and 1 month. The general prevalence of anti-HBc reagent was 0.1%, HBsAg was 0.02% and anti-HCV was 0.02%. CONCLUSIONS In children, the general prevalence of serological markers for hepatitis B and C in the city of Santos was low when compared with literature data.
Memorias Do Instituto Oswaldo Cruz | 2016
Ana Paula de Torres Santos; José Eduardo Levi; Marcílio Figueiredo Lemos; Samira Julien Calux; Isabel Takano Oba; Regina Célia Moreira
This study aimed to standardise an in-house real-time polymerase chain reaction (rtPCR) to allow quantification of hepatitis B virus (HBV) DNA in serum or plasma samples, and to compare this method with two commercial assays, the Cobas Amplicor HBV monitor and the Cobas AmpliPrep/Cobas TaqMan HBV test. Samples from 397 patients from the state of São Paulo were analysed by all three methods. Fifty-two samples were from patients who were human immunodeficiency virus and hepatitis C virus positive, but HBV negative. Genotypes were characterised, and the viral load was measure in each sample. The in-house rtPCR showed an excellent success rate compared with commercial tests; inter-assay and intra-assay coefficients correlated with commercial tests (r = 0.96 and r = 0.913, p < 0.001) and the in-house test showed no genotype-dependent differences in detection and quantification rates. The in-house assay tested in this study could be used for screening and quantifying HBV DNA in order to monitor patients during therapy.
Revista Da Associacao Medica Brasileira | 2014
Ana Paula de Torres Santos; José Eduardo Levi; Marcílio Figueiredo Lemos; Samira Julien Calux; Isabel Takano Oba; Regina Célia Moreira
Objective: the aim of this study was to identify HBV genotypes in serum samples from patients from the state of Sao Paulo, received by the viral hepatitis laboratory, at the Virology Centre of Instituto Adolfo Lutz, from various municipalities. Methods: a total of 94 serum samples were randomly analyzed. Genotyping was performed using nested PCR for amplification of S and Pol regions from viral genome. Genotypes were identified comparing the sequences obtained with the sequences deposited in GenBank. Results: we were able to determine the genotype of 91 (97%) samples, as follows: genotype A (55.3%), D (32%), F (5.3%), C (3.2%) and G (1%). There are few data on the epidemiology of genotype G. This genotype has been detected in restricted areas around the world. Frequently, the genotype G infection occurs in HIV-positive male patients. In our case, the sample identified as G was also positive for HIV but in a female patient, which is an uncommon finding in the scientific literature. Conclusion: in this work, we identified the most frequent genotypes in Sao Paulo as well as the genotype G, rare among the genotypes found in our environment.
Revista de Ciências Médicas e Biológicas | 2009
Dhélio Batista Pereira; Kelly Regia Vieira de Oliveira; Regina Célia Moreira; Isabel Takano Oba; Adriana Parise Compri; Marcílio Figueiredo Lemos; Mariana Vasconcelos; Juan Miguel Villalobos Salcedo
Patients under hemodialysis treatment for chronic renal failure (CRF) are among the groups with the highest prevalence of hepatitis B and C viruses due to frequent blood transfusions and nosocomial transmission. A group of CRF patients living in Porto Velho were tested with serological markers for hepatitis B and C using the ELISA test and molecular biology techniques (PCR). The validity parameters for the serological results were measured based on the PCR results. Of the 128 patients on hemodialysis during the study, 12 (9.4%) were HBsAg positive, 69 (53.9%) were anti-HBc positive, 93 (72.7%) were anti-HBs positive, and 22 (17.2%) were anti-HCV positive. The PCR tests result in 12 (9.4%) HBV-DNA positive and 16 (12.5%) HCV-RNA positive. The accuracy, sensitivity and specificity of ELISA for HBsAg were 90.6%, 50% and 94.8%, and the same parameters were 92.2%, 87.5% and 92.9% for anti-HCV. Based on the results just the negative predictive value for anti-HCV (98,2%) is a reliable test in CRF patients on hemodialysis. Beside that, serial serological and/or molecular tests are the indicated methodology to diagnosis HBV and HCV infection in these patients.